Home/Filings/4/0001415889-21-000896
4//SEC Filing

MANNING JOSEPH J 4

Accession 0001415889-21-000896

CIK 0000001800other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 7:01 PM ET

Size

7.8 KB

Accession

0001415889-21-000896

Insider Transaction Report

Form 4
Period: 2021-02-19
MANNING JOSEPH J
Senior Vice President
Transactions
  • Award

    Option (right to buy)

    2021-02-19+66,65866,658 total
    Exercise: $124.04From: 2022-02-19Exp: 2031-02-18Common Shares (66,658 underlying)
  • Award

    Common shares without par value

    2021-02-19+13,00461,707 total
Footnotes (3)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Since the date of the reporting person's last ownership report, he transferred 10,978 shares and employee stock options to purchase shares 178,060 in the aggregate to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 22,219 on February 19, 2022, 22,219 on February 19, 2023, and 22,220 on February 19, 2024.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001695686

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 7:01 PM ET
Size
7.8 KB